Dimethyltryptamine molecule:

Image from PubChem

DMT Clinical Trials

A Double-Blind, Randomized, Phase 1, First-in-Human, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of Intranasal 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in Healthy Subjects

To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05032833

Organisation Name: Beckley Psytech Limited

Overal Status: Completed

Start Date: September 22, 2021

Last Update: October 12, 2022

Lead Sponsor: Beckley Psytech Limited

Brief Summary: The study will evaluate safety, tolerability and PK profile of 5-MeO-DMT in healthy subjects

  • Pharmacokinetics in Healthy Adults

Total execution time in seconds: 0.277498960495